{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:53:21Z","timestamp":1793962401306,"version":"4.8.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Cerebral amyloid angiopathy (CAA) is characterized by the accumulation of \u03b2-amyloid (A\u03b2) in the walls of cerebral vessels, leading to complications such as intracerebral hemorrhage, convexity subarachnoid hemorrhage and cerebral microinfarcts. Patients with CAA-related intracerebral hemorrhage are more likely to develop dementia and strokes. Several pathological investigations have demonstrated that more than 90% of Alzheimer\u2019s disease patients have concomitant CAA, suggesting common pathogenic mechanisms. Potential causes of CAA include impaired A\u03b2 clearance from the brain through the intramural periarterial drainage (IPAD) system. Conversely, CAA causes restriction of IPAD, limiting clearance. Early intervention in CAA could thus prevent Alzheimer\u2019s disease progression. Growing evidence has suggested Taxifolin (dihydroquercetin) could be used as an effective therapy for CAA. Taxifolin is a plant flavonoid, widely available as a health supplement product, which has been demonstrated to exhibit anti-oxidative and anti-inflammatory effects, and provide protection against advanced glycation end products and mitochondrial damage. It has also been shown to facilitate disassembly, prevent oligomer formation and increase clearance of A\u03b2 in a mouse model of CAA. Disturbed cerebrovascular reactivity and spatial reference memory impairment in CAA are completely prevented by Taxifolin treatment. These results highlight the need for clinical trials on the efficacy and safety of Taxifolin in patients with CAA<\/jats:p>","DOI":"10.3389\/fphar.2021.643357","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T22:28:11Z","timestamp":1613255291000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy"],"prefix":"10.3389","volume":"12","author":[{"given":"Satoshi","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Satoh-Asahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana Octavia","family":"Carare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5114\/aoms.2011.20612","article-title":"Tramiprosate in mild-to-moderate Alzheimer\u2019s disease\u2014a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)","volume":"7","author":"Aisen","year":"2011","journal-title":"Arch. Med. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00401-013-1145-2","article-title":"Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer\u2019s disease mouse models","volume":"126","author":"Arbel-Ornath","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/STROKEAHA.117.019409","article-title":"Cognitive impairment before intracerebral hemorrhage is associated with cerebral amyloid angiopathy","volume":"49","author":"Banerjee","year":"2018","journal-title":"Stroke"},{"key":"B4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","article-title":"Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons","volume":"85","author":"Boyle","year":"2015","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.pneurobio.2011.09.004","article-title":"Biomarkers in clinical trials for neurodegenerative diseases: regulatory perspectives and requirements","volume":"95","author":"Broich","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/STROKEAHA.119.026244","article-title":"Risk of intracerebral hemorrhage and mortality after convexity subarachnoid hemorrhage in cerebral amyloid angiopathy","volume":"50","author":"Calviere","year":"2019","journal-title":"Stroke"},{"key":"B8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2990.2007.00926.x","article-title":"Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology","volume":"34","author":"Carare","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e12053","DOI":"10.1002\/dad2.12053","article-title":"Clearance of interstitial fluid (ISF) and CSF (CLIC) group\u2014part of vascular professional interest area (PIA)","volume":"12","author":"Carare","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e12050","DOI":"10.1002\/trc2.12050","article-title":"Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"B13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00702-020-02174-2","article-title":"Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy","volume":"127","author":"Fakan","year":"2020","journal-title":"J. Neural. Transm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s12603-009-0106-x","article-title":"Effect of tramiprosate in patients with mild-to-moderate Alzheimer\u2019s disease: exploratory analyses of the MRI sub-group of the Alphase study","volume":"13","author":"Gauthier","year":"2009","journal-title":"J. Nutr. Health Aging"},{"key":"B15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2006.02.015","article-title":"Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis","volume":"28","author":"Gervais","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"B16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/STROKEAHA.117.016990","article-title":"Diagnosis of cerebral amyloid angiopathy: evolution of the boston criteria","volume":"49","author":"Greenberg","year":"2018","journal-title":"Stroke"},{"key":"B17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/01.wad.0000213845.28624.f4","article-title":"A phase 2 study of tramiprosate for cerebral amyloid angiopathy","volume":"20","author":"Greenberg","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.taap.2015.06.002","article-title":"Taxifolin protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload","volume":"287","author":"Guo","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yfrne.2018.06.001","article-title":"Precision medicine and drug development in Alzheimer\u2019s disease: the importance of sexual dimorphism and patient stratification","volume":"50","author":"Hampel","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1271\/bbb.60.945","article-title":"Protection against oxidative damage by dihydroflavonols in Engelhardtia chrysolepis","volume":"60","author":"Haraguchi","year":"1996","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1055\/s-0030-1250161","article-title":"Inhibition of advanced glycation end product formation by medicinal plant extracts correlates with phenolic metabolites and antioxidant activity","volume":"77","author":"Harris","year":"2011","journal-title":"Planta Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"10031","DOI":"10.1073\/pnas.1901659116","article-title":"Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy","volume":"116","author":"Inoue","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1161\/STROKEAHA.119.028202","article-title":"Cortical microinfarcts detected by 3-tesla magnetic resonance imaging: differentiation between cerebral amyloid angiopathy and embolism","volume":"51","author":"Ishikawa","year":"2020","journal-title":"Stroke"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1003956","DOI":"10.1371\/journal.pcbi.1003956","article-title":"Epidemic spreading model to characterize misfolded proteins propagation in aging and associated neurodegenerative disorders","volume":"10","author":"Iturria-Medina","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1161\/STROKEAHA.119.028487","article-title":"Strictly lobar microbleeds reflect amyloid angiopathy regardless of cerebral and cerebellar compartments","volume":"51","author":"Jung","year":"2020","journal-title":"Stroke"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2015.08.024","article-title":"Deposition of amyloid \u03b2 in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy","volume":"1862","author":"Keable","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40478-020-01042-0","article-title":"Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer's disease mouse model","volume":"8","author":"Kim","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1212\/WNL.0b013e3181d55efa","article-title":"Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies","volume":"74","author":"Kumar","year":"2010","journal-title":"Neurology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/acn3.761","article-title":"Immunotherapy with ponezumab for probable cerebral amyloid angiopathy","volume":"6","author":"Leurent","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"B30","first-page":"19","article-title":"Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue","volume":"3","author":"Love","year":"2014","journal-title":"Am J Neurodegener. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s40478-020-01009-1","article-title":"Demonstrating a reduced capacity for removal of fluid from cerebral white matter and hypoxia in areas of white matter hyperintensity associated with age and dementia","volume":"8","author":"MacGregor Sharp","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00401-016-1555-z","article-title":"Vascular basement membranes as pathways for the passage of fluid into and out of the brain","volume":"131","author":"Morris","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/WNR.0b013e32832d2e6a","article-title":"Cortical microinfarcts in Alzheimer\u2019s disease and subcortical vascular dementia","volume":"20","author":"Okamoto","year":"2009","journal-title":"Neuroreport"},{"key":"B36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00401-011-0925-9","article-title":"Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts","volume":"123","author":"Okamoto","year":"2012","journal-title":"Acta Neuropathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1212\/WNL.0000000000004797","article-title":"Mixed-location cerebral hemorrhage\/microbleeds: underlying microangiopathy and recurrence risk","volume":"90","author":"Pasi","year":"2018","journal-title":"Neurology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.2353\/ajpath.2006.060269","article-title":"Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer\u2019s disease patients: a biochemical analysis","volume":"169","author":"Patton","year":"2006","journal-title":"Am. J. Pathol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fnagi.2020.00015","article-title":"Vital functions contribute to the spread of extracellular fluids in the brain: comparison between life and death","volume":"12","author":"Piotrowska","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000499032","article-title":"Finger-like projections in lobar haemorrhage on early magnetic resonance imaging is associated with probable cerebral amyloid angiopathy","volume":"47","author":"Renard","year":"2019","journal-title":"Cerebrovasc. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1474-4422(18)30006-1","article-title":"The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study","volume":"17","author":"Rodrigues","year":"2018","journal-title":"Lancet Neurol."},{"key":"B42","first-page":"158","article-title":"Chemical and neuropathological analyses of an Alzheimer\u2019s disease patient treated with solanezumab","volume":"5","author":"Roher","year":"2016","journal-title":"Am J Neurodegener Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuroscience.2020.05.024","article-title":"Impaired amyloid beta clearance and brain microvascular dysfunction are present in the tg-SwDI mouse model of alzheimer\u2019s disease","volume":"440","author":"Rosas-Hernandez","year":"2020","journal-title":"Neuroscience"},{"key":"B44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/YCO.0000000000000239","article-title":"Interaction between cerebrovascular disease and Alzheimer pathology","volume":"29","author":"Saito","year":"2016","journal-title":"Curr. Opin. Psychiatr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fnagi.2014.00290","article-title":"New therapeutic approaches for Alzheimer\u2019s disease and cerebral amyloid angiopathy","volume":"6","author":"Saito","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"538456","DOI":"10.3389\/fnagi.2020.538456","article-title":"Cerebral amyloid angiopathy presenting as massive subarachnoid haemorrhage: a case study and review of literature","volume":"12","author":"Saito","year":"","journal-title":"Front. Aging Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"615780","DOI":"10.3389\/fnagi.2020.615780","article-title":"Editorial: intramural vascular cells: key therapeutic targets for vascular cognitive impairment","volume":"12","author":"Saito","year":"","journal-title":"Front. Aging Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fneur.2019.00490","article-title":"Development of a multicomponent intervention to prevent alzheimer\u2019s disease","volume":"10","author":"Saito","year":"2019","journal-title":"Front. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/1567205012666150530202508.","article-title":"Mild cognitive impairment: at the crossroad of neurodegeneration and vascular dysfunction","volume":"12","author":"Saito","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40478-017-0429-5","article-title":"Taxifolin inhibits amyloid-\u03b2 oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy","volume":"5","author":"Saito","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/ene.14031","article-title":"Nationwide survey on cerebral amyloid angiopathy in Japan","volume":"26","author":"Sakai","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1271\/bbb.120925","article-title":"Structure-activity relationship for (+)-taxifolin isolated from silymarin as an inhibitor of amyloid \u03b2 aggregation","volume":"77","author":"Sato","year":"","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"23212","DOI":"10.1074\/jbc.M113.464222","article-title":"Site-specific inhibitory mechanism for amyloid \u03b242 aggregation by catechol-type flavonoids targeting the Lys residues","volume":"288","author":"Sato","year":"","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"B55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1161\/STROKEAHA.119.024150","article-title":"New treatment approaches to modify the course of cerebral small vessel diseases","volume":"51","author":"Smith","year":"2020","journal-title":"Stroke"},{"key":"B56","doi-asserted-by":"publisher","first-page":"112066","DOI":"10.1016\/j.phytochem.2019.112066","article-title":"An insight into the health-promoting effects of taxifolin (dihydroquercetin)","volume":"166","author":"Sunil","year":"2019","journal-title":"Phytochemistry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","article-title":"The role of brain vasculature in neurodegenerative disorders","volume":"21","author":"Sweeney","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092139","article-title":"Novel therapeutic potentials of taxifolin for amyloid-\u03b2-associated neurodegenerative diseases and other diseases: recent advances and future perspectives","volume":"20","author":"Tanaka","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21061992","article-title":"Potential therapeutic approaches for cerebral amyloid angiopathy and alzheimer\u2019s disease","volume":"21","author":"Tanaka","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00401-020-02140-y","article-title":"Histopathology of diffusion-weighted imaging-positive lesions in cerebral amyloid angiopathy","volume":"139","author":"Ter Telgte","year":"2020","journal-title":"Acta Neuropathol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","article-title":"Cerebral amyloid angiopathy and its relationship to Alzheimer's disease","volume":"115","author":"Thal","year":"2008","journal-title":"Acta Neuropathol."},{"key":"B64","unstructured":"2020"},{"key":"B65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1212\/WNL.0000000000003486","article-title":"\u03b2-Amyloid in CSF: biomarker for preclinical cerebral amyloid angiopathy","volume":"88","author":"van Etten","year":"2017","journal-title":"Neurology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1474-4422(16)30346-5","article-title":"Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study","volume":"16","author":"van Opstal","year":"2017","journal-title":"Lancet Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1148\/radiol.13130743","article-title":"Increased number of microinfarcts in Alzheimer disease at 7-T MR imaging","volume":"270","author":"van Rooden","year":"2014","journal-title":"Radiology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ana.21694","article-title":"Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy","volume":"66","author":"Verbeek","year":"2009","journal-title":"Ann. Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s11011-018-0207-5","article-title":"Taxifolin prevents \u03b2-amyloid-induced impairments of synaptic formation and deficits of memory via the inhibition of cytosolic phospholipase A2\/prostaglandin E2 content","volume":"33","author":"Wang","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejphar.2012.03.035","article-title":"Dihydroquercetin: more than just an impurity?","volume":"684","author":"Weidmann","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1212\/WNL.0b013e31828c2f52","article-title":"Estimating cerebral microinfarct burden from autopsy samples","volume":"80","author":"Westover","year":"2013","journal-title":"Neurology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3233\/JAD-190346","article-title":"Predictors for late post-intracerebral hemorrhage dementia in patients with probable cerebral amyloid angiopathy","volume":"71","author":"Xiong","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"117037","DOI":"10.1016\/j.jns.2020.117037","article-title":"Proportion of intracerebral haemorrhage due to cerebral amyloid angiopathy in the East and West: comparison between single hospital centres in Japan and the United Kingdom","volume":"416","author":"Yakushiji","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5853\/jos.2015.17.1.17","article-title":"Cerebral amyloid angiopathy: emerging concepts","volume":"17","author":"Yamada","year":"2015","journal-title":"J Stroke"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21091209","article-title":"Detection of 191 taxifolin metabolites and their distribution in rats using HPLC-ESI-IT-TOF-MS(n)","volume":"21","author":"Yang","year":"2016","journal-title":"Molecules"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.643357\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T22:28:17Z","timestamp":1613255297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.643357\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":75,"alternative-id":["10.3389\/fphar.2021.643357"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.643357","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"article-number":"643357"}}